Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Patent Law

: Philip Brooks’ Patent Infringement Updates

Pfizer Sues Mylan Over Patents for Top-Drug Lipitor

By Philip Brooks

ADVERTISEMENTS

The following is excerpted from a June 15, 2009 article by Phil Milford and Susan Decker at Bloomberg:

Pfizer Inc., the world?s biggest drugmaker, sued rival Mylan Inc. asking a judge to prohibit sales of a generic version of its cholesterol-fighting medicine Lipitor until 2017.

In federal court papers filed today in Wilmington, Delaware, lawyers for New York-based Pfizer contend a Mylan affiliate has applied to the U.S. Food and Drug Administration for permission to sell copies of Lipitor, the world?s best- selling drug, before three Pfizer patents expire.

Pfizer officials have said they?re looking for cooperative ventures with other pharmaceutical makers to increase generic sales as patents expire. Lipitor logged $12.4 billion in revenue last year, $7.7 billion of it in the U.S.

Ranbaxy Laboratories Ltd., India?s biggest drugmaker and majority owned by Japan?s Daiichi Sankyo Co., settled a lawsuit filed by Pfizer and plans to enter the market in November 2011. Pfizer already is suing Apotex Inc. and Teva Pharmaceutical Industries Ltd. to prevent them from selling copies of the medicine before then.

Read the full article here.

Full post as published by Philip Brooks’ Patent Infringement Updates on June 17, 2009 (boomark / email).